Tengion (TNGN) Stock Price, News & Analysis

Company Overview

Tengion, Inc. is a biotechnology company specializing in regenerative medicine and tissue engineering. Headquartered in the United States, the company focuses on developing autologous cell therapies and tissue-engineered organs to address unmet medical needs in urology, gastroenterology and vascular medicine. Its technology platform leverages patient-specific cells and a proprietary scaffold to regenerate functional tissues that can replace or repair damaged organs.

The company’s lead product candidates include the Neo-Urinary Conduit and Neo-Bladder Augment, both designed to restore urinary tract function in patients with congenital anomalies, trauma or disease. These therapies have undergone early- to mid-stage clinical trials in North America and Europe, demonstrating the potential for improved patient outcomes and reduced long-term complications. Tengion has also explored additional indications, such as vascular grafts and gastrointestinal tissue repair, through strategic collaborations with academic institutions and clinical partners.

Founded in 2003 as a spin-out from pioneering research in tissue engineering, Tengion relocated its operations to Winston-Salem, North Carolina, to expand its research and development capabilities. The company is guided by an executive team with extensive experience in cell therapy development, clinical trial management and regulatory affairs. Through its board of directors and scientific advisors, Tengion continues to advance its pipeline, foster industry partnerships and explore new applications for its regenerative medicine platform.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 10,000 shs
• Average Volume: 6,051 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TNGN Stock Analysis - Frequently Asked Questions

How do I buy shares of Tengion?

Shares of TNGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:TNGN
• CIK: 1296391
• Web: www.tengion.com
• Phone: (336) 722-5855
• Fax: N/A
• Employees: 25
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A